⌘K

ASND · Categories · Upgrades

ASND - Analyst upgrades

Ascendis Pharma A/S (ASND) analyst upgrades - real-time wire coverage filtered to Upgrades only.

Recent Upgrades for ASND

491d
Ascendis Pharma upgraded by Morgan Stanley with a new price target
Morgan Stanley upgraded Ascendis Pharma from Equal-Weight to Overweight and set a new price target of $250.00
733d
Ascendis Pharma upgraded by Oppenheimer with a new price target
Oppenheimer upgraded Ascendis Pharma from Perform to Outperform and set a new price target of $180.00
805d
Ascendis Pharma upgraded by TD Cowen with a new price target
TD Cowen upgraded Ascendis Pharma from Hold to Buy and set a new price target of $175.00 from $156.00 previously
1638d
Ascendis Pharma upgraded by BofA Securities with a new price target
BofA Securities upgraded Ascendis Pharma from Neutral to Buy and set a new price target of $161.00 from $148.00 previously
1667d
Ascendis Pharma upgraded by Oppenheimer with a new price target
Oppenheimer upgraded Ascendis Pharma from Perform to Outperform and set a new price target of $170.00

Other ASND categories